Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Topics : Neurodegenerative diseases
Active substance : atropine

Topic

Diseases and conditions (1)
Plus ...
- Nervous system diseases (1)
- Plus ...
  - Neurodegenerative diseases (1)

Practice Guidelines and Other Guides (1)
Plus ...
- Practice guidelines (1)

Français (1)

Active substance

atropine (1)
gabapentine (1)
modafinil (1)
quinine (1)
riluzole (1)
scopolamine (1)
sulfate de quinidine (1)
zopiclone (1)

Practice guidelines and other guides - 1 result

Care of patients with amyotrophic lateral sclerosis (ALS) (23-24 November 2004)

Practice guidelines - Posted on 2/2/2006

Download abstract

Add to my selection

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

m3Y9zmxGnTzNQU76